Stephens Lowers Amedisys (NASDAQ:AMED) Price Target to $106.00
Amedisys (NASDAQ:AMED - Get Rating) had its price objective lowered by investment analysts at Stephens from ...
Read moreAmedisys (NASDAQ:AMED - Get Rating) had its price objective lowered by investment analysts at Stephens from ...
Read moreAmedisys (NASDAQ:AMED - Get Rating) had its price target dropped by investment analysts at SVB Leerink ...
Read more© 2022 TheDailyStock.News